{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:27:39Z","timestamp":1791160059643,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5428,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.nurt.2008.08.007","type":"journal-article","created":{"date-parts":[[2008,10,4]],"date-time":"2008-10-04T15:11:21Z","timestamp":1223133081000},"page":"499-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Spinal Muscular Atrophy"],"prefix":"10.1016","volume":"5","author":[{"given":"Maryam","family":"Oskoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2008.08.007_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01668496","article-title":"\u00dcber chronische spinale Muskelatrophie im Kindesalter, auf famili\u00e4rer Basis","volume":"3","author":"Hoffmann","year":"1893","journal-title":"Dtsch Z Nervenheilkd"},{"key":"10.1016\/j.nurt.2008.08.007_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF01776636","article-title":"Zwei fr\u00fchinfantile heredit\u00e4re F\u00e4lle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber auf neurotischer Grundlage","volume":"22","author":"Werdnig","year":"1891","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10.1016\/j.nurt.2008.08.007_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/345823a0","article-title":"Genetic homogeneity between acute and chronic forms of spinal muscular atrophy","volume":"345","author":"Gilliam","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.08.007_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2008.08.007_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib6","series-title":"Neuromuscular disorders of infancy, childhood, and adolescence: a clinician's approach","first-page":"145","article-title":"Spinal muscular atrophies","author":"Crawford","year":"2003"},{"key":"10.1016\/j.nurt.2008.08.007_bib7","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000290830.40544.b9","article-title":"The changing natural history of spinal muscular atrophy type 1","volume":"69","author":"Oskoui","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11910-004-0016-6","article-title":"Spinal muscular atrophy","volume":"4","author":"Iannaccone","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nurt.2008.08.007_bib9","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","article-title":"A novel nuclear structure containing the survival of motor neurons protein","volume":"15","author":"Liu","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.nurt.2008.08.007_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/hmg\/ddi168","article-title":"Gemins modulate the expression and activity of the SMN complex","volume":"14","author":"Feng","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib11","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly","volume":"298","author":"Pellizzoni","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.08.007_bib12","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1073\/pnas.0610660104","article-title":"Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis","volume":"104","author":"Setola","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.08.007_bib13","doi-asserted-by":"crossref","first-page":"8622","DOI":"10.1523\/JNEUROSCI.3967-05.2006","article-title":"Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons","volume":"26","author":"Zhang","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.08.007_bib14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/hmg\/ddg157","article-title":"Neuromuscular defects in a Drosophila survival motor neuron gene mutant","volume":"12","author":"Chan","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.200610053","article-title":"A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle","volume":"176","author":"Rajendra","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nurt.2008.08.007_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Participants of the International Conference on SMA Standard of Care","volume":"22","author":"Wang","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.PHM.0000083669.22483.04","article-title":"Prevention of pectus excavatum for children with spinal muscular atrophy type 1","volume":"82","author":"Bach","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nurt.2008.08.007_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1378\/chest.117.4.1100","article-title":"Spinal muscular atrophy type 1: a noninvasive respiratory management approach","volume":"117","author":"Bach","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.nurt.2008.08.007_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1469-8749.1999.tb00520.x","article-title":"Cognitive predictors of young children's readiness for powered mobility","volume":"41","author":"Tefft","year":"1999","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ptj\/83.3.253","article-title":"Use of power mobility for a young child with spinal muscular atrophy","volume":"83","author":"Jones","year":"2003","journal-title":"Phys Ther"},{"key":"10.1016\/j.nurt.2008.08.007_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.sc.3100496","article-title":"Clinical and functional evaluation of a gaze controlled system for the severely handicapped","volume":"36","author":"Thoumie","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.nurt.2008.08.007_bib22","unstructured":"O'Hagen JM, Ryan P, Wei Y, Kaufmann P, De Vivo DC. The effect of a gravity neutral orthosis on disability in children with SMA type 1. Paper presented at: 11th Annual International Spinal Muscular Atrophy Research Group Meeting, Schaumburg, IL, June 21\u201323, 2007."},{"key":"10.1016\/j.nurt.2008.08.007_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.60.11.1601","article-title":"A phase 1 trial of riluzole in spinal muscular atrophy","volume":"60","author":"Russman","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/CND.0b013e3180315c99","article-title":"A randomized, placebo-controlled trial of creatine in children with spinal muscular atrophy","volume":"8","author":"Wong","year":"2007","journal-title":"J Clin Neuromusc Dis"},{"key":"10.1016\/j.nurt.2008.08.007_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jmg.2007.051177","article-title":"Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells","volume":"45","author":"Angelozzi","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib27","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2008.08.007_bib28","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib29","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.08.007_bib30","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.20548","article-title":"Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells","volume":"58","author":"Grzeschik","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1212\/01.wnl.0000183282.10946.c7","article-title":"Challenges and opportunities in clinical trials for spinal muscular atrophy","volume":"65","author":"Hirtz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","article-title":"A placebo-controlled trial of gabapentin in spinal muscular atrophy","volume":"191","author":"Miller","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2008.08.007_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/08830738030180080501","article-title":"Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study","volume":"18","author":"Merlini","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00002060-200009000-00005","article-title":"A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report","volume":"79","author":"Tzeng","year":"2000","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nurt.2008.08.007_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.007_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy","volume":"68","author":"Mercuri","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1212\/01.wnl.0000251192.70723.80","article-title":"Learning to walk: challenges for spinal muscular atrophy clinical trials","volume":"68","author":"Kaufmann","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0883073807305665","article-title":"Perspectives on clinical trials in spinal muscular atrophy","volume":"22","author":"Swoboda","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2007.11.012","article-title":"The effect of hydroxyurea in spinal muscular atrophy cells and patients","volume":"268","author":"Liang","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2008.08.007_bib42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate","volume":"59","author":"Brichta","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","article-title":"Valproate may improve strength and function in patients with type III\/IV spinal muscle atrophy","volume":"67","author":"Weihl","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(95)00032-1","article-title":"Spinal muscular atrophy","volume":"6","author":"Munsat","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.007_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nmd.2006.12.001","article-title":"Issues in SMA clinical trial design","volume":"17","author":"Kaufmann","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.007_bib46","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneur.59.9.1445","article-title":"Outcome measures for pediatric spinal muscular atrophy","volume":"59","author":"Iannaccone","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib47","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archneur.60.8.1130","article-title":"Reliability of 4 outcome measures in pediatric spinal muscular atrophy","volume":"60","author":"Iannaccone","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nmd.2005.11.010","article-title":"Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study","volume":"16","author":"Mercuri","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.007_bib49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mus.20018","article-title":"Motor function\u2013muscle strength relationship in spinal muscular atrophy","volume":"29","author":"Merlini","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.007_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation","volume":"7","author":"Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0197-2456(01)00153-2","article-title":"Considerations in the evaluation of surrogate endpoints in clinical trials: summary of a National Institutes of Health workshop","volume":"22","author":"De Gruttola","year":"2001","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.nurt.2008.08.007_bib52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","article-title":"Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies","volume":"41","author":"Lesko","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.nurt.2008.08.007_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn\u2212\/\u2212 mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib54","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib55","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/hmg\/9.5.849","article-title":"Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy","volume":"9","author":"Frugier","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.expneurol.2008.02.025","article-title":"Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy","volume":"212","author":"El-Khodor","year":"2008","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.nurt.2008.08.007_bib57","first-page":"A403","article-title":"Beneficial effects of valproic acid (VPA) and hydroxyurea (HU) in a mouse model of spinal muscular atrophy (SMA)","volume":"68","author":"Winberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib58","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.nmd.2007.06.069","article-title":"Challenges of enrollment for SMA type I clinical trials","volume":"17","author":"Iannaccone","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.007_bib59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy","volume":"15","author":"Pearn","year":"1978","journal-title":"J Med Genet"},{"key":"10.1016\/j.nurt.2008.08.007_bib60","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nmd.2007.06.057","article-title":"The natural history of spinal muscular atrophy: preliminary results from the PNCR Network","volume":"17","author":"Kaufmann","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.007_bib61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.61.4.456","article-title":"A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis","volume":"61","author":"Cudkowicz","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib62","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Western ALS Study Group","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2008.08.007_bib63","first-page":"133","article-title":"Clinical advances in pediatric hematology & oncology: cooperative group research","volume":"3","author":"Reaman","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.nurt.2008.08.007_bib64","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/djh270","article-title":"Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2","volume":"96","author":"Widemann","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nurt.2008.08.007_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1043454204264406","article-title":"Pediatric cancer research from past successes through collaboration to future transdisciplinary research","volume":"21","author":"Reaman","year":"2004","journal-title":"J Pediatr Oncol Nurs"},{"issue":"Suppl 1","key":"10.1016\/j.nurt.2008.08.007_bib66","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/00042560-200207011-00006","article-title":"International collaboration in conducting systematic reviews: the Cochrane Collaborative Review Group on HIV Infection and AIDS","volume":"30","author":"Kennedy","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nurt.2008.08.007_bib67","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/01.wnl.0000201182.60750.66","article-title":"A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS","volume":"66","author":"Levy","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.007_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/17482960600888156","article-title":"Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial","volume":"8","author":"Kaufmann","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nurt.2008.08.007_bib69","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbadis.2006.06.004","article-title":"Cellular therapies in motor neuron diseases","volume":"1762","author":"Nayak","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nurt.2008.08.007_bib70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(02)00835-8","article-title":"Directed differentiation of embryonic stem cells into motor neurons","volume":"110","author":"Wichterle","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2008.08.007_bib71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/WNR.0b013e3280b10c2c","article-title":"Functional motoneurons develop from human neural stem cell transplants in adult rats","volume":"18","author":"Gao","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.nurt.2008.08.007_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2004.10.033","article-title":"Human neural stem cell-derived cholinergic neurons innervate muscle in motoneuron deficient adult rats","volume":"131","author":"Gao","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nurt.2008.08.007_bib73","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1073\/pnas.0401103101","article-title":"Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats","volume":"101","author":"Harper","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.08.007_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.20901","article-title":"Recovery from paralysis in adult rats using embryonic stem cells","volume":"60","author":"Deshpande","year":"2006","journal-title":"Ann Neurol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2008.08.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:38:46Z","timestamp":1761806326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923004610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1878747923004610"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2008.08.007","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal Muscular Atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2008.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}